RVNC vs. T

Last updated Jun 4, 2026

RVNC (Revance Therapeutics, Inc.) and T (AT&T Inc.) are both stocks. RVNC operates in Biotechnology (Healthcare), while T operates in Telecom Services (Communication Services).

Performance

RVNC vs. T - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revance Therapeutics, Inc. (RVNC) and AT&T Inc. (T). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RVNC

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

T

• 1D: -4.42%
• 1M: -9.77%
• YTD: -3.08%
• 6M: -4.92%
• 1Y: -12.10%
• 3Y*: 22.12%
• 5Y*: 7.39%
• 10Y*: 3.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RVNC vs. T - Yearly Performance Comparison

	2026 (YTD)
RVNC Revance Therapeutics, Inc.	0.00%
T AT&T Inc.	-12.29%

Fundamentals

Total Revenue (TTM) RVNC : $247.00M T : $125.65B
Gross Profit (TTM) RVNC : $174.52M T : $105.41B
EBITDA (TTM) RVNC : -$150.16M T : $54.70B

Return for Risk

RVNC vs. T — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

T

T Risk / Return Rank: 17
T Sharpe Ratio Rank: 17
T Sortino Ratio Rank: 16
T Omega Ratio Rank: 17
T Calmar Ratio Rank: 19
T Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVNC vs. T - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revance Therapeutics, Inc. (RVNC) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RVNC	T	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.56	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.31	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.15	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.38	—

Drawdowns

RVNC vs. T - Drawdown Comparison

The maximum RVNC drawdown since its inception was 0.00%, smaller than the maximum T drawdown of -64.15%. Use the drawdown chart below to compare losses from any high point for RVNC and T.

Drawdown Indicators

	RVNC	T	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-64.15%	+64.15%
Max Drawdown (1Y) Largest decline over 1 year	—	-20.60%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-20.60%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-32.01%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-42.35%	—
Current Drawdown Current decline from peak	0.00%	-18.23%	+18.23%
Average Drawdown Average peak-to-trough decline	0.00%	-15.72%	+15.72%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	10.08%	—

Volatility

Volatility by Period

	RVNC	T	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.96%	—
Volatility (6M) Calculated over the trailing 6-month period	—	17.27%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	21.86%	-21.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	23.92%	-23.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	23.69%	-23.69%

Dividends

RVNC vs. T - Dividend Comparison

RVNC has not paid dividends to shareholders, while T's dividend yield for the trailing twelve months is around 4.71%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RVNC Revance Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
T AT&T Inc.	4.71%	4.47%	4.87%	6.62%	6.66%	8.46%	7.23%	5.22%	7.01%	5.04%	4.51%	5.46%

Financials